Lucid Diagnostics Retained Earnings (Accumulated Deficit) 2021-2025 | LUCD

Lucid Diagnostics retained earnings (accumulated deficit) from 2021 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Lucid Diagnostics Retained Earnings (Accumulated Deficit) 2021-2025 | LUCD

Lucid Diagnostics retained earnings (accumulated deficit) from 2021 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$174.6B
Intuitive Surgical (ISRG)$169.1B
IDEXX Laboratories (IDXX)$52.2B
Edwards Lifesciences (EW)$45.9B
Alcon (ALC)$41.8B
IQVIA Holdings (IQV)$30.6B
DexCom (DXCM)$30.5B
Mettler-Toledo (MTD)$25.9B
STERIS (STE)$23.8B
Waters (WAT)$16.6B
SONOVA HOLDING (SONVY)$16.4B
Hologic (HOLX)$15.1B
Penumbra (PEN)$9.3B
Sysmex ADR (SSMXY)$8.7B
Globus Medical (GMED)$8B
Masimo (MASI)$8B
Teleflex (TFX)$5.1B
Glaukos (GKOS)$5B
TransMedics (TMDX)$4.3B
Integer Holdings (ITGR)$3.7B
LivaNova (LIVN)$2.7B
Alphatec Holdings (ATEC)$2.3B
Veracyte (VCYT)$2.2B
PROCEPT BioRobotics (PRCT)$2.2B
Nihon Kohden (NHNKY)$2.1B
Artivion (AORT)$2B
Elekta AB (EKTAY)$1.9B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1B
Pulse Biosciences (PLSE)$1B